"Recombinant human follicle stimulating hormone for injection", Changchun hi tech's first generic drug, is expected to go on the market next year

Yang Zhanmin, chairman of Changchun hi tech, said at the 2013 performance presentation meeting that the company is currently promoting the on-site inspection and GMP certification of the first generic drug "recombinant human follicle stimulating hormone for injection" to strive for the product to be listed next year Recombinant human follicle stimulating hormone for injection is used to treat infertility At present, only imported products are on sale in the market with high price Changchun hi tech was informed on December 30 last year that the product will enter the site for inspection According to the website of the State Food and drug administration, at present, Changchun hi tech has submitted an application form and is in the stage of formulating an inspection plan The next step is to organize on-site inspection Yang Zhanmin said that while deepening the development of existing recombinant proteins such as growth hormone and varicella vaccines, the company will actively seek to expand new fields In the future, the company will focus on innovative antibodies, gene recombinant vaccines, bioengineering materials and other related fields, and develop innovative biological products for major fields such as tumors, immune system diseases, cardio cerebrovascular diseases and diabetes 。 According to him, the long-acting exenatide microsphere of Baiyi pharmaceutical is under pre clinical study.